Xtandi (enzalutamide) Disease area(s): Oncology Manufacturer(s): Astellas/Pfizer 2024 Sales (USD): $7.94 billion Why it sold so well: In 2024, Astellas Pharmas Xtandi, co-marketed with Pfizer, posted strong sales growth, with revenues reaching 703.1 billion ($4.64 billion) for the first nine months (April 1, 2024 to December 31, 2024), marking a 25.6% increase compared to the same period in the previous year
5B, Supplementary Fig
Joseph Ramos leads the clinical team
NNC Rating 4.4 Trusted Compounding Pharmacies All-in monthly* $279/mo Coaching Minimal Lifestyle Support Insurance No Pros and Cons PROS Affordable compounded GLP-1s GLP-1 tablets or injections 24/7 expert support Money-back weight-loss guarantee All-inclusive pricing Fast process from intake to delivery Current promo $120 off your first month CONS Does not accept insurance Extremely expensive Ozempic No coaching or nutritional guidance Disorganized appointment system Price Transparency MEDVi has a simple pricing structure that includes your initial consultation, the cost of your medication, all necessary supplies, free shipping, unlimited messaging to your provider, and 24/7 support
At Femina Atlanta, pelvic health physical therapy takes a whole-body approach to address the underlying contributors to these symptoms and help restore more efficient movement and function
Krass M, Volke A, Rnkorg K, Wegener G, Lund S, Abildgaard A, et al